Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells

Fusion-positive rhabdomyosarcoma (FP-RMS) is a highly aggressive childhood malignancy which is mainly treated by conventional chemotherapy, surgery and radiation therapy. Since radiotherapy is associated with a high burden of late side effects in pediatric patients, addition of radiosensitizers woul...

Descripción completa

Detalles Bibliográficos
Autores principales: Brack, Eva, Bender, Sabine, Wachtel, Marco, Pruschy, Martin, Schäfer, Beat W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239363/
https://www.ncbi.nlm.nih.gov/pubmed/34211841
http://dx.doi.org/10.3389/fonc.2021.664462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239363/
https://www.ncbi.nlm.nih.gov/pubmed/34211841
http://dx.doi.org/10.3389/fonc.2021.664462

Ejemplares similares